| Literature DB >> 35402806 |
Junwei Zhu1,2, Yunxiao Ren1,2,3, Yuanyuan Han4, Tingting Jin4, Yanming Li1, Xiuyan Ruan1, Hongzhu Qu1, Shengwen Huang4, Zhaojun Zhang1,2,3, Xiangdong Fang1,2,3,5.
Abstract
Erythropoiesis is a complex and sophisticated multi-stage process regulated by a variety of factors, including the transcription factor GATA1 and non-coding RNA. GATA1 is regarded as an essential transcriptional regulator promoting transcription of erythroid-specific genes-such as long non-coding RNAs (lncRNA). Here, we comprehensively screened lncRNAs that were potentially regulated by GATA1 in erythroid cells. We identified a novel lncRNA-PCED1B-AS1-and verified its role in promoting erythroid differentiation of K562 erythroid cells. We also predicted a model in which PCED1B-AS1 participates in erythroid differentiation via dynamic chromatin remodeling involving GATA1. The relationship between lncRNA and chromatin in the process of erythroid differentiation remains to be revealed, and in our study we have carried out preliminary explorations.Entities:
Keywords: Chromatin accessibility; Erythroid differentiation; Long non-coding RNA; PCED1B-AS1
Year: 2019 PMID: 35402806 PMCID: PMC8975080 DOI: 10.1097/BS9.0000000000000031
Source DB: PubMed Journal: Blood Sci ISSN: 2543-6368
FIGURE 1Identification and functional verification of lncRNA PCED1B-AS1. (A) Dynamic expression of lncRNA PCED1B-AS1 during erythroid differentiation in Blueprint database. (B) Relative expression of PCED1B-AS1 during late stage of erythroid differentiation of CD34+ cells. The horizontal axis represents the days after EPO induction. (C) The confirmation of PCED1B-AS1 overexpression in K562 cells by RT-PCR. D3 represents the cells induced with hemin for 3 days. (D) The analysis for globin gene expression changes before and after induction of PCED1B-AS1-overexpressed K562 cells compared with that in control cells. HBE, HBG and HBB are β-like genes that respectively represent ε (embryonic)-, γ (fetal)- and β (adult)-globin and are specifically expressed at different developmental stages during erythroid differentiation. (E) The expression changes of CD235a and CD71 was detected by flow cytometry before and after induction. The percentage in the upper right of each figure represents the proportion of CD235a+-CD71+ double positive cells. (F) Percentage of CD235a+-CD71+ double positive cells among the K562 cells before and after induction. Data are the means ± SD of three experimental replicates. N.S. = no significance between samples. (G,H) Benzidine-stained positive rate changes of K562 cells before and after induction with hemin. All relative mRNA expression was normalized to GAPDH. Statistical results were analyzed by student t-test and Kruskal−Wallis test, ∗P < .05, ∗∗P < .01, ∗∗∗P < .001, nsP > .05, ns: no significance. D0: Day0, D3: Day3. Ctr: Control, OE: overexpression of PCED1B-AS1.
FIGURE 2The association between lncRNA PCED1B-AS1 and chromatin accessibility during erythroid differentiation. (A) Dynamic profile of chromatin accessibility and histone modification of H3K27ac around PCED1B-AS1 loci during erythroid differentiation. (B) Confirmation of physical binding of GATA1 around PCED1B-AS1 loci by ChIP-qPCR in K562 cells. Rank1 and Rank2 are from the red box on the left side in (A) picture, and Rank3 and Rank4 are from the red box on the right side in (A). The bar graphs represent the average of percentage input (mean ± SD) from three independent ChIP experiments. (C) Known motif identification of peaks within 20 kb of PCED1B-AS1. (D) Regulation factors of PCED1B-AS1 within its 100 kb genomic regions in EB. (E) Relative expression of PCED1B-AS1 in TF-1 cells with GATA1 knockdown by siRNA. (F) Correlation between PCED1B-AS1 with its potential target genes. (G) Model of PCED1B-AS1 participates in erythroid differentiation via dynamic chromatin remodeling involving GATA1.